PleaseReview is already extensively used throughout Life Science companies, but we have high hopes of expanding this even further thanks to our most recent integration with another significant and rapidly growing player in this sector, Veeva Systems.
Last week we announced the integration between PleaseReview and Veeva Vault.
A match made in heaven, well at least in the Cloud.
Whilst we have several platform integrations in place which are based around on premise installations, and have many cloud customers, this is our first purely cloud-based integration.
Veeva are specialists in cloud-based software for the Life Sciences Industry, and their Vault platform provides regulated content management applications that touch just about every part of a life sciences company - from clinical trials, to manufacturing, regulatory submissions, medical communications and marketing. PleaseReview tackles the specific task of collaborative document co-authoring and review which, in the document-intensive and heavily regulated Life Sciences sector, is also applicable across departments and disciplines.
The process is straightforward and user administration is managed in a single location. In practice, users simply login to PleaseReview, select documents stored within the controlled Veeva Vault repository, review and edit them within PleaseReview’s controlled collaborative environment and then check them directly back into Veeva without leaving PleaseReview.
As Life Sciences is such a regulated industry, control is a necessary consideration and a key element of both products’ success. In fact, the synergy between PleaseTech and Veeva is so strong that it led to customers asking for this integration. Now PleaseReview can be used in conjunction with Veeva’s Submissions, QualityDocs, eTMF, MedComms and PromoMats Vaults.
We are just finalizing plans with Veeva to host a joint webinar to show how it all works in a little more detail, and I hope to be able to share that with you shortly. If you wish to be kept informed, just let us know.